In a recent study, researchers examined the effectiveness of text messaging to support the use of pre-exposure prophylaxis use in certain patient populations who are at high-risk of HIV infection.
Researchers aimed to determine the risk profile of individuals without HIV who were seeking vaccination against mpox and if these patients would benefit from HIV pre-exposure prophylaxis use.
To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...
Researchers compared pre-exposure prophylaxis (PrEP) use with birth outcomes using objective levels of tenofovir-diphosphate (TFV-DP) in dried blood spots (DBS) of women during the second or third trimester...
Researchers examined the efficacy of post-exposure prophylaxis for the prevention of sexually transmitted infections among certain patient populations living with HIV or on HIV pre-exposure prophylaxis.
...
In order to explore the relationship between arrhythmias and outcomes among this population, the researchers conducted a study using data from the NIS database on 2005-2014 HIV hospitalizations.
The FDA has approved a new option for the treatment of HIV-1 in adults as a replacement for current antiretroviral regimens in patients who are virologically suppressed and with no history of treatment...
